Literature DB >> 3611298

Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

I Julkunen, P Ukkonen, M Stenvik, T Hovi, L Renkonen, O Mäkelä.   

Abstract

Immunoglobulin isotype composition of poliovirus antibodies was studied by isotype-specific solid-phase radio-immunoassay (RIA) in four patients with paralytic poliomyelitis, five adults receiving live poliovirus vaccine as a booster immunization, and seven children receiving first doses of inactivated poliovirus vaccine. In paralytic poliomyelitis serum and cerebrospinal fluid (CSF) poliovirus antibodies were mainly of IgG1, IgG3, and IgA isotypes. IgM antibodies were found in sera but not in CSF. Either IgG2 and IgG4 antibodies were undetectable or the titers were low. In adults who had received live trivalent poliovirus vaccine, antibodies against poliovirus type 3 were detected in IgG1 (53% of total antibodies), IgG3 (25%), IgM (9%), IgA (8%), IgG2 (3%), and IgG4 (2%) isotypes. In prevaccination and late postvaccination sera the share of IgG3 antibodies was exceptionally high (35%). In children who received inactivated poliovirus vaccine, antibodies developed in IgG1 (53-61% of total antibodies for poliovirus types 1, 2, and 3), IgG3 (12-21%), and IgM (23-33%) isotypes. Antibody levels in IgG2, IgG4, and IgA isotypes were low and observed only in a few cases. Like other viral antibodies IgG1 and IgG3 isotypes were the major IgG subclasses in poliovirus antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611298     DOI: 10.1007/bf00915554

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.

Authors:  B Vandvik; J B Natvig; E Norrby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

2.  Isotype concentrations of human antibodies to group A meningococcal polysaccharide.

Authors:  N Rautonen; J Pelkonen; S Sipinen; H Käyhty; O Mäkelä
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

3.  Protein kinase activity in purified poliovirus particles and empty viral capsid preparations.

Authors:  C E Schärli; G Koch
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

4.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

5.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

6.  Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients.

Authors:  P Ukkonen; M L Granström; J Räsänen; E M Salonen; K Penttinen
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

7.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  The subclasses of human IgG antibodies against tetanus toxoid.

Authors:  M van der Giessen; O Groenboer-Kempers
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  Relative immunogenicity in mice of different regions of the human IgG.

Authors:  A Sarnesto; S Ranta; I J Seppälä; O Mäkelä
Journal:  Scand J Immunol       Date:  1983-06       Impact factor: 3.487

10.  Subclass distribution of rubella virus-specific immunoglobulin G.

Authors:  G A Linde
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

View more
  4 in total

1.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Intrathecal immune response and virus-specific immunoglobulin M antibodies in laboratory diagnosis of acute poliomyelitis.

Authors:  M Roivainen; M Agboatwalla; M Stenvik; T Rysä; D S Akram; T Hovi
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays.

Authors:  P Ukkonen; J Korpela; J Suni; K Hedman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

4.  Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.

Authors:  G Zackrisson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.